Princeton Capital Management Inc’s Regeneron Pharmaceuticals REGN Stock Holding History

Princeton Capital Management Inc’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	$1.7M	Buy	3,791 +1,280	+51%	+$609K	0.86%	36
2017 Q2	$1.23M	Buy	2,511 +15	+0.6%	+$6.56K	0.78%	39
2017 Q1	$967K	Buy	2,496 +157	+7%	+$58.2K	0.61%	45
2016 Q4	$859K	Buy	2,339 +104	+5%	+$39.5K	0.57%	40
2016 Q3	$899K	Buy	2,235 +284	+15%	+$114K	0.59%	44
2016 Q2	$681K	Buy	1,951 +1,140	+141%	+$439K	0.47%	46
2016 Q1	$292K	Buy	+811	New	+$334K	0.2%	61

Other funds holding REGN

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Princeton Capital Management Inc's REGN Position: Q3 2017 in Review

Princeton Capital Management Inc increased its Regeneron Pharmaceuticals (REGN) stake by 51% in Q3 2017, buying an estimated $609K and bringing the position to 3,791 shares worth $1.7M. The position accounts for 0.86% of the portfolio, ranked #36.

Princeton Capital Management Inc first reported a position in REGN in Q1 2016 and has held it in 7 quarters since. 605 funds tracked by Wall St. Rank hold REGN as of Q3 2017.

Princeton Capital Management Inc held 3,791 shares of Regeneron Pharmaceuticals worth $1.7M as of Q3 2017.
Princeton Capital Management Inc bought 1,280 Regeneron Pharmaceuticals shares in Q3 2017, an estimated $609K.
Regeneron Pharmaceuticals made up 0.86% of Princeton Capital Management Inc's portfolio in Q3 2017, its #36 holding.
Princeton Capital Management Inc first reported a position in Regeneron Pharmaceuticals in Q1 2016 and has held it in 7 quarters since.
605 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2017.

Based on Princeton Capital Management Inc's 13F filing for Q3 2017, filed 3 Nov 2017.